These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazine. Herishanu Y; Lishner M; Kitay-Cohen Y Anticancer Drugs; 2002 Feb; 13(2):177-9. PubMed ID: 11901312 [TBL] [Abstract][Full Text] [Related]
4. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma. Treudler R; Georgieva J; Geilen CC; Orfanos CE J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966 [TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature. Mohammadianpanah M; Shirazi M; Mosalaei A; Omidvari S; Ahmadloo N Clin Ther; 2007 Jun; 29(6):1161-5. PubMed ID: 17692730 [TBL] [Abstract][Full Text] [Related]
6. [Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):500. PubMed ID: 16760848 [No Abstract] [Full Text] [Related]
7. Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients. Teimouri F; Nikfar S; Abdollahi M Melanoma Res; 2013 Oct; 23(5):381-9. PubMed ID: 23880781 [TBL] [Abstract][Full Text] [Related]
8. An ambiguous phenomenon of radiation and drugs: recall reactions. Caloglu M; Yurut-Caloglu V; Cosar-Alas R; Saynak M; Karagol H; Uzal C Onkologie; 2007 Apr; 30(4):209-14. PubMed ID: 17396045 [TBL] [Abstract][Full Text] [Related]
9. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study. Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514 [TBL] [Abstract][Full Text] [Related]
10. Radiation recall dermatitis from high-dose interferon alfa-2b. Thomas R; Stea B J Clin Oncol; 2002 Jan; 20(1):355-7. PubMed ID: 11773198 [No Abstract] [Full Text] [Related]
18. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone. Kanat O; Baskan BE; Kurt E; Evrensel T J Postgrad Med; 2007; 53(2):146. PubMed ID: 17495388 [No Abstract] [Full Text] [Related]
19. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733 [TBL] [Abstract][Full Text] [Related]
20. Recurrent radiation recall dermatitis triggered by radiological procedures in a patient with breast cancer. Emre S; Demirseren DD; Unal E; Sungu N Australas J Dermatol; 2019 Nov; 60(4):308-310. PubMed ID: 31012084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]